32 related articles for article (PubMed ID: 38627251)
21. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
22. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
23. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review.
Nguyen M; Joshi SG
J Appl Microbiol; 2021 Dec; 131(6):2715-2738. PubMed ID: 33971055
[TBL] [Abstract][Full Text] [Related]
24. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
Maragakis LL; Perl TM
Clin Infect Dis; 2008 Apr; 46(8):1254-63. PubMed ID: 18444865
[TBL] [Abstract][Full Text] [Related]
25. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Kempf M; Rolain JM
Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
[TBL] [Abstract][Full Text] [Related]
26. Dihydrophenazine: a multifunctional new weapon that kills multidrug-resistant Acinetobacter baumannii and restores carbapenem and oxidative stress susceptibilities.
Mahdally NH; ElShiekh RA; Thissera B; Eltaher A; Osama A; Mokhtar M; Elhosseiny NM; Kashef MT; Magdeldin S; El Halawany AM; Rateb ME; Attia AS
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38627251
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ibrahim ME
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
[TBL] [Abstract][Full Text] [Related]
29. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.
Viehman JA; Nguyen MH; Doi Y
Drugs; 2014 Aug; 74(12):1315-33. PubMed ID: 25091170
[TBL] [Abstract][Full Text] [Related]
30. Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
Gontijo AVL; Pereira SL; de Lacerda Bonfante H
Curr Microbiol; 2021 Dec; 79(1):13. PubMed ID: 34905109
[TBL] [Abstract][Full Text] [Related]
31. Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.
Nowak P; Paluchowska P
Folia Histochem Cytobiol; 2016; 54(2):61-74. PubMed ID: 27270503
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
